Movement Alert|UNISOUND Rises 18.08% in Regular Trading, Interim Results Beat Expectations with Token Business Surging 760%

Market Focus
Yesterday

On August 31, UNISOUND rose 18.08% in regular trading, trading at HKD 76.4/share, with turnover of HKD 552 million. The rally was driven by the company's stronger-than-expected interim results released on August 28.

UNISOUND reported H1 revenue of RMB 562 million, up 38.7% year-over-year, with gross margin improving to 33.1%. The standout was its Token business, which generated nearly RMB 30 million in revenue, surging 760% year-over-year. Notably, Q2 alone contributed over RMB 25 million, representing sequential growth exceeding 500%, with gross margins above 60%. This growth was primarily driven by USD-denominated revenue, signaling that the pay-per-token API model is gaining commercial traction. Enterprise intelligent services contributed RMB 478 million, up 35.7%, while edge AI revenue reached approximately RMB 53.8 million. The net loss ratio narrowed by over 31 percentage points year-over-year. Additionally, the company recently launched its U2-RadiMed medical imaging multimodal model and secured two municipal-level AI platform contracts totaling over RMB 20 million.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10